Related Experiment Videos
Rapidly progressive glomerulonephritis in Behçet's syndrome
JAMA
|October 10, 1980
Summary
Transfer factor therapy did not prevent rapidly progressive glomerulonephritis in a patient with Behçet's syndrome. This treatment is not recommended for Behçet's syndrome patients experiencing kidney complications.
Area of Science:
- Nephrology
- Immunology
- Rheumatology
Background:
- Behçet's syndrome is a multisystem inflammatory disorder.
- Renal involvement, including glomerulonephritis, can occur in Behçet's syndrome.
- Transfer factor is an immunomodulatory agent.
Observation:
- A patient with Behçet's syndrome developed rapidly progressive glomerulonephritis.
- The patient was undergoing treatment with transfer factor at the time of diagnosis.
Findings:
- Transfer factor therapy did not prevent the onset of rapidly progressive glomerulonephritis.
- The immunomodulatory effects of transfer factor did not protect against renal pathology in this case.
Implications:
- Transfer factor is not a recommended treatment for preventing or managing renal complications in Behçet's syndrome.
- Further research is needed to explore effective therapies for renal involvement in Behçet's syndrome.